Cite
HARVARD Citation
Berek, J. et al. (2014). Catumaxomab for the Treatment of Malignant Ascites in Patients With Chemotherapy-Refractory Ovarian Cancer: A Phase II Study. International journal of gynecological cancer. 24 (9), pp. 1583-1589. [Online].